You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response

Area of Science:

• Immunology
• Virology
• Respiratory Medicine

Background:

• Type I interferons (IFNα/β) and Type III interferons (IFNλ) are critical for antiviral responses.
• Both interferon types exhibit overlapping antiviral functions, particularly within the lung.
• The distinct roles of IFNλ and IFNα/β in specific viral infections remain an active area of research.

Purpose of the Study:

• To investigate the specific role of Type III interferon (IFNλ) in the lung during influenza virus infection.
• To determine if IFNλ offers unique protective mechanisms not provided by Type I interferons (IFNα/β).
• To elucidate the early-acting functions of IFNλ in antiviral defense.

Main Methods:

• Influenza virus infection models in mice.
• Analysis of interferon expression and signaling pathways.
• Assessment of immune cell infiltration and viral load in lung tissue.

Main Results:

• Type III interferon (IFNλ) demonstrated a critical, early protective role in the lung following influenza infection.
• This protective function of IFNλ was found to be distinct and not replicated by Type I interferons (IFNα/β).
• IFNλ's early action is key to limiting viral spread and associated lung damage.

Conclusions:

• Type III interferon (IFNλ) is essential for early antiviral defense in the lung against influenza.
• IFNλ provides a non-redundant protective mechanism compared to Type I interferons (IFNα/β) during this specific infection.
• Targeting IFNλ may represent a novel therapeutic strategy for influenza and other respiratory viral infections.